ICON BIOSCIENCE
IBI is developing a broad portfolio of clinically superior proprietary products, based on its Verisome® drug delivery technology. The company’s initial focus is on its pipeline of reduced-risk, low-cost development programs targeting every major ophthalmic market. IBI’s lead portfolio product, IBI-10090 completed enrollment in its pivotal phase 2/3 clinical trial, in December 2012. An NDA is planned for late 2013. It was founded in 2004 and headquartered in Sunnyvale, California.
ICON BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.iconbioscience.com
Total Employee:
11+
Status:
Active
Contact:
650-369-4049
Total Funding:
37.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NextWave Pharmaceuticals
NextWave Pharmaceuticals develops and commercializes products utilizing proprietary drug delivery technology.
Souvie Biodelivery
Souvie Biodelivery develops drug delivery services with the goal of marketing novel drug delivery platforms to drug delivery niche markets.
Zogenix
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Current Employees Featured
Founder
Official Site Inspections
http://www.iconbioscience.com
- Host name: ssdcloudserver.net
- IP address: 162.213.123.219
- Location: Latham United States
- Latitude: 42.747
- Longitude: -73.7527
- Metro Code: 532
- Timezone: America/New_York
- Postal: 12110
More informations about "Icon Bioscience"
About | My Canadian Pharmacy: Favorable HealthCare Giver
Icon Bioscience, Inc. is developing a broad portfolio of clinically superior proprietary products, based on its Verisome® drug delivery technology.See details»
Icon Bioscience - Crunchbase Company Profile & Funding
IBI is developing a broad portfolio of clinically superior proprietary products, based on its Verisome® drug delivery technology. The company’s initial focus is on its pipeline of reduced …See details»
Icon Bioscience Company Profile | Management and Employees …
Www.iconbioscience.com Icon Bioscience Profile and History Icon Bioscience, Inc. is a privately held specialty biopharmaceutical company focused on the development and commercialization …See details»
Icon Bioscience - Overview, News & Competitors | ZoomInfo.com
Icon Bioscience. Manufacturing · California, United States · <25 Employees . Icon Bioscience, Inc. is a privately held specialty biopharmaceutical company focused on the development and …See details»
Icon Bioscience - PitchBook
Icon Bioscience General Information Description. Developer of a bio-pharma platform designed to deliver injectable ophthalmic drug-device combination therapeutics. The company's bio …See details»
About Us | My Canadian Pharmacy: Favorable HealthCare Giver
About Us. The main goal of My Canadian Pharmacy is to provide consumers with the opportunity to buy high-quality products at affordable prices in Canadian pharmacies.See details»
Icon Bioscience, Inc.:Company Profile & Technical …
Icon Bioscience, Inc. is a company that provides Clinical trial, Medical equipment, Eye drop and more. Icon Bioscience, Inc. is headquartered in United States California.See details»
Icon Bioscience Inc Overview - Salary.com
Discover essential details about Icon Bioscience Inc, including address, contact, and journey of our company's evolution.See details»
Icon Bioscience Inc. - BioCentury Company Profiles - BCIQ
Apr 13, 2018 Icon Bioscience Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Icon Bioscience, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Icon Bioscience, Inc. of Watertown, MA. Get the latest business insights from Dun & Bradstreet.See details»
Icon Bioscience - Ownership and Business Overview - Mergr
Mar 28, 2018 www.iconbioscience.com. Profile Investors (1) Analytics Icon Bioscience, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of …See details»
Icon Bioscience - Products, Competitors, Financials, Employees ...
PSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital... Jan 17, 2019. transformation to a specialty biopharmaceutical company with the potential to …See details»
Overview | My Canadian Pharmacy: Favorable HealthCare Giver
Overview. IBI is focused on developing a broad portfolio of clinically superior proprietary products, based on its Verisome® drug delivery technology.See details»
Icon Bioscience, Inc. Overview | SignalHire Company Profile
Phone Number: 1-510-933-8380: Icon Bioscience, Inc. industries Pharma, Health Care Services: Headquarters LocationSee details»
Icon Bioscience, Inc. - Drug pipelines, Patents, Clinical trials
The study is a prospective, randomized, parallel-design, multicenter trial in patients ≥40 years of age undergoing cataract surgery. Patients who meet all inclusion and no exclusion criteria will …See details»
Icon Bioscience, Inc. (Icon Bioscience, Inc.) - 药物管线_专利_临床试 …
Www.iconbioscience.com. 更新于：2024-11-01. ... primarily due to a decrease in external clinical research organization costs, in addition to a decrease in IBD program expenses due to …See details»
Icon Bioscience’s Founder Honored by Foundation Fighting …
Icon Bioscience’s Founder Honored by Foundation Fighting Blindness. SUNNYVALE, Calif–Icon Bioscience, Inc., a specialty biopharmaceutical company focused on utilizing its Verisome® …See details»
Pipeline | My Canadian Pharmacy: Favorable HealthCare Giver
Pipeline. The Icon Bioscience development pipeline consists of a broad portfolio of advanced, biodegradable, sustained-released intraocular pharmaceutical products based on Verisome ® …See details»
Icon Bioscience Achieves Key Milestone with IBI-10090 Advancing …
Icon Bioscience Achieves Key Milestone with IBI-10090 Advancing Through Phase 3 Studies. SUNNYVALE, Calif.–Icon Bioscience, Inc., a specialty biopharmaceutical company focused on …See details»